[HLFG] QoQ TTM Result on 31-Mar-2022 [#3]

Announcement Date
30-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2022
Quarter
31-Mar-2022 [#3]
Profit Trend
QoQ- 0.01%
YoY- 6.04%
View:
Show?
TTM Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 6,496,830 6,337,356 6,251,516 6,107,187 6,184,293 6,259,364 6,198,872 3.17%
PBT 5,161,762 4,927,804 4,839,979 4,459,193 4,392,529 4,158,139 3,971,507 19.03%
Tax -1,082,474 -1,170,420 -1,157,118 -928,973 -862,749 -672,037 -595,146 48.84%
NP 4,079,288 3,757,384 3,682,861 3,530,220 3,529,780 3,486,102 3,376,361 13.39%
-
NP to SH 2,704,737 2,493,387 2,452,209 2,350,892 2,350,687 2,318,783 2,265,254 12.51%
-
Tax Rate 20.97% 23.75% 23.91% 20.83% 19.64% 16.16% 14.99% -
Total Cost 2,417,542 2,579,972 2,568,655 2,576,967 2,654,513 2,773,262 2,822,511 -9.78%
-
Net Worth 25,266,612 24,583,927 24,365,371 23,801,505 23,482,032 23,015,915 22,823,171 6.99%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 545,579 522,868 522,868 501,143 501,143 453,515 453,515 13.07%
Div Payout % 20.17% 20.97% 21.32% 21.32% 21.32% 19.56% 20.02% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 25,266,612 24,583,927 24,365,371 23,801,505 23,482,032 23,015,915 22,823,171 6.99%
NOSH 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 0.00%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 62.79% 59.29% 58.91% 57.80% 57.08% 55.69% 54.47% -
ROE 10.70% 10.14% 10.06% 9.88% 10.01% 10.07% 9.93% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 572.89 558.88 549.32 538.58 545.42 552.07 546.74 3.15%
EPS 238.50 219.89 215.48 207.32 207.32 204.52 199.80 12.49%
DPS 48.00 46.00 46.00 44.20 44.20 40.00 40.00 12.88%
NAPS 22.28 21.68 21.41 20.99 20.71 20.30 20.13 6.97%
Adjusted Per Share Value based on latest NOSH - 1,147,516
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 566.16 552.27 544.79 532.21 538.93 545.47 540.20 3.16%
EPS 235.70 217.29 213.70 204.87 204.85 202.07 197.40 12.51%
DPS 47.54 45.57 45.57 43.67 43.67 39.52 39.52 13.07%
NAPS 22.0185 21.4236 21.2331 20.7417 20.4633 20.0571 19.8892 6.99%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 18.60 18.46 18.50 19.60 17.34 18.30 17.80 -
P/RPS 3.25 3.30 3.37 3.64 3.18 3.31 3.26 -0.20%
P/EPS 7.80 8.40 8.59 9.45 8.36 8.95 8.91 -8.46%
EY 12.82 11.91 11.65 10.58 11.96 11.18 11.22 9.26%
DY 2.58 2.49 2.49 2.26 2.55 2.19 2.25 9.52%
P/NAPS 0.83 0.85 0.86 0.93 0.84 0.90 0.88 -3.81%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 28/02/23 29/11/22 30/08/22 30/05/22 28/02/22 29/11/21 30/08/21 -
Price 18.22 19.00 19.42 19.46 19.32 17.24 18.24 -
P/RPS 3.18 3.40 3.54 3.61 3.54 3.12 3.34 -3.21%
P/EPS 7.64 8.64 9.01 9.39 9.32 8.43 9.13 -11.17%
EY 13.09 11.57 11.10 10.65 10.73 11.86 10.95 12.60%
DY 2.63 2.42 2.37 2.27 2.29 2.32 2.19 12.94%
P/NAPS 0.82 0.88 0.91 0.93 0.93 0.85 0.91 -6.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment